Lido Advisors
ANGO icon

Lido Advisors’s AngioDynamics ANGO Stock Holding History

Lido Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,440
Closed -$370K – 987
2021
Q4 		$370K Buy
13,440
+4,709
+54% +$130K ﹤0.01% 725
2021
Q3 		$226K Buy
+8,731
New +$233K ﹤0.01% 862

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Lido Advisors's ANGO Position: Q1 2022 in Review

Lido Advisors sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 13,440 shares — an estimated $370K sold.

Lido Advisors first reported a position in ANGO in Q3 2021 and held it in 2 quarters. The position peaked at $370K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

  • Lido Advisors reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
  • Lido Advisors sold 13,440 AngioDynamics shares in Q1 2022, an estimated $370K.
  • Lido Advisors first reported a position in AngioDynamics in Q3 2021 and held it in 2 quarters.
  • Lido Advisors's AngioDynamics position peaked at $370K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on Lido Advisors's 13F filing for Q1 2022, filed 17 May 2022.